Sunday 18 October 2026
Export NUWE’s income statement to Excel — free account
Nuwellis, Inc.
NUWE Healthcare Medical Devices
Nuwellis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.3 million, down 5.38% from fiscal 2024. In the quarter to June 2026, revenue grew 14.1%, EPS grew 98.8% and free cash flow fell 51.6%, each against the same quarter a year earlier.
0.55
0.00
0.00%
Follow NUWE
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
3 | — | — | — | — | 5 | 4 | 5 | 4 | 4 |
P/S ratio |
0.15 | 0.17 | 0.00 | 0.00 | 0.00 | 7,947,078.16 | 1,951,010.89 | 85,588,590.18 | 103,927,553.22 | 9,819,696,209.25 |
Altman Z-Score |
(76.39) | (44.17) | — | — | — | 9,604,888.78 | 1,785,986.11 | 90,374,281.47 | 97,126,445.15 | 1,718,305,953.32 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(177.65) | (99.99) | (104.20) | (34.15) | (19.97) | (34.19) | (146.91) | (80.96) | (24.31) | (88.11) |
Beneish M-Score |
(7.71) | (3.46) | (2.96) | (1.80) | (2.15) | (2.27) | (1.61) | 0.28 | (1.13) | — |
P/Operating CF |
(0.40) | (0.98) | 0.00 | 0.00 | 0.00 | (17,346,497.08) | (2,667,995.29) | (157,442,684.47) | (117,186,479.41) | (5,487,371,461.75) |
P/B ratio |
0.46 | 0.23 | 0.00 | 0.00 | 0.00 | 3,623,863.74 | 5,403,025.63 | 72,063,978.05 | 22,740,152.52 | 8,523,071,553.27 |
Price to Tangible BV |
0.00 | 0.58 | 0.00 | 0.00 | 0.00 | 4,802,973.40 | 0.00 | 221,643,406.06 | 30,187,589.65 | 0.00 |
EV/Sales |
0.49 | 0.04 | 0.02 | (1.68) | (2.56) | 7,947,076.75 | 1,951,011.42 | 85,588,590.26 | 103,927,550.50 | 9,819,696,212.25 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.85 | 1.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(0.38) | (0.03) | (0.01) | 0.95 | 1.13 | (3,568,319.94) | (656,933.09) | (29,379,929.54) | (30,977,733.80) | (919,165,033.37) |
EV/FCF |
(0.37) | (0.03) | (0.01) | 0.94 | 1.12 | (3,511,740.49) | (637,837.33) | (28,985,755.12) | (30,301,541.68) | (912,611,172.14) |
Quick Ratio |
0.85 | 2.67 | 1.81 | 4.20 | 7.55 | 4.28 | 0.62 | 2.21 | 7.72 | 0.49 |
Current Ratio |
1.71 | 3.46 | 2.59 | 4.86 | 8.51 | 5.17 | 1.20 | 2.86 | 8.54 | 0.74 |
Net Debt/EBITDA |
0.10 | 0.48 | 0.22 | 1.09 | 1.27 | 0.86 | 0.06 | 0.33 | 1.55 | 0.09 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.09% | 0.27% | 4.66% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.03 | 0.89 | 0.51 | 0.31 | 0.31 | 0.58 | 0.77 | 0.37 | 0.27 | 0.08 |
Operating CF/Net income |
0.62 | 0.90 | 0.79 | 1.04 | 0.91 | 0.94 | 0.72 | 0.85 | 0.48 | 0.92 |
Capex/Depreciation |
(0.45) | (0.19) | (0.69) | (0.33) | (0.45) | (0.71) | (2.05) | (0.85) | (0.05) | (0.13) |
Interest Coverage |
(1.05) | (1.96) | (5.06) | (1.86) | — | — | — | — | — | (31.08) |
| (382.80%) | (223.24%) | (294.87%) | (75.84%) | (92.53%) | (192.19%) | (570.86%) | (153.62%) | (277.54%) | (254.05%) | |
| (219.21%) | (108.22%) | (131.39%) | (52.73%) | (77.55%) | (137.37%) | (314.69%) | (125.09%) | (192.64%) | (110.85%) | |
ROIC |
(449.27%) | (478.57%) | 0.00% | 0.00% | (689.48%) | (550.00%) | (1,164.22%) | (2,334.98%) | (1,439.74%) | (1,065.15%) |
Return on Tangible Assets |
(694.57%) | (156.83%) | (392.49%) | (76.20%) | (75.19%) | (108.93%) | (1,349.82%) | (292.50%) | (152.80%) | 5,877.74% |
Average Days of Receivables |
65.89 | 72.12 | 80.34 | 60.07 | 34.56 | 44.39 | 52.92 | 57.40 | 55.99 | 79.85 |
Research and Development Expense of Revenue |
32.79% | 36.72% | 61.17% | 50.83% | 62.85% | 49.29% | 84.78% | 61.08% | 41.68% | 629.09% |
Selling, General and Administrative Expense of Revenue |
163.46% | 153.95% | 193.94% | 205.83% | 240.36% | 234.07% | 295.50% | 306.34% | 286.24% | 630.64% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.60 |
Share Based Compensation of Revenue |
1.54% | 5.47% | 7.56% | 10.09% | 16.59% | 18.13% | 27.44% | 41.76% | 14.04% | 73.62% |
Graham Net Nets |
1.42 | 3.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(5,220.16%) | (3,882.71%) | (1,947.61%) | (1,179.59%) | (35.91%) | (175.35%) | (883.50%) | (94.44%) | (13.00%) | (0.22%) |
Free Cash Flow Yield |
(911.62%) | (658.14%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
419.80 | 9,711.11 | 0.00 | 0.00 | 0.00 | 4.51 | 68.04 | 12.37 | 74.02 | 39.06 |
Operating CF per Share |
(548.73) | (10,656.67) | 0.00 | 0.00 | 0.00 | (10.05) | (202.06) | (36.04) | (248.33) | (493.70) |
Capex per Share |
(4.57) | (66.67) | 0.00 | 0.00 | 0.00 | (0.16) | (6.05) | (0.49) | (5.40) | (3.55) |
Free Cash Flow per Share |
(553.30) | (10,723.33) | 0.00 | 0.00 | 0.00 | (10.21) | (208.11) | (36.53) | (253.73) | (497.24) |
Cash per Share |
55.08 | 5,661.11 | 0.00 | 0.00 | 0.00 | 8.76 | 15.79 | 13.56 | 324.90 | 40.09 |
Shareholders Equity per Share |
133.50 | 7,255.56 | 0.00 | 0.00 | 0.00 | 9.90 | 24.57 | 14.69 | 338.29 | 67.94 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
133.50 | 7,255.56 | 0.00 | 0.00 | 0.00 | 9.90 | 24.57 | 14.69 | 338.29 | 67.94 |
Free Cash Flow |
(10.90) | (9.65) | (18.18) | (15.27) | (18.06) | (16.84) | (16.86) | (14.76) | (12.18) | (16.41) |
Working Capital |
2.15 | 6.30 | 5.04 | 18.08 | 24.82 | 14.95 | 0.69 | 5.29 | 15.77 | (0.84) |
Capital Expenditures |
(0.09) | (0.06) | (0.25) | (0.12) | (0.22) | (0.27) | (0.49) | (0.20) | (0.26) | (0.12) |
Net Current Asset Value |
1.70 | 5.52 | 1.65 | 10.45 | 23.66 | 14.84 | 0.42 | 5.29 | 15.65 | (2.81) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.84 | 1.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.03 | 0.01 | 0.03 | 0.04 | 0.09 | 0.04 | 0.07 | 0.09 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.54 | 0.65 | 0.50 | 0.38 | 0.41 | 0.31 | 0.24 | 0.43 | 8.28 | 1.64 |
Cash ROIC |
(293.41%) | (83.02%) | (259.38%) | (49.80%) | (35.99%) | (54.66%) | (477.54%) | (129.27%) | (38.26%) | (460.28%) |
Accounts Receivable Turnover |
5.14 | 4.75 | 5.28 | 7.92 | 9.57 | 8.73 | 6.95 | 7.51 | 8.59 | 7.56 |
Accounts Payable Turnover |
1.63 | 1.52 | 1.68 | 2.07 | 2.73 | 2.62 | 2.03 | 3.68 | 1.94 | 0.30 |
Inventory Turnover |
1.73 | 1.65 | 1.67 | 1.38 | 1.18 | 1.42 | 1.54 | 2.26 | 2.44 | 0.63 |
Average Days of Payables |
258.26 | 195.37 | 223.83 | 216.32 | 150.47 | 118.32 | 204.18 | 112.68 | 113.87 | 1,017.19 |
Days of Inventory on Hand |
221.60 | 204.66 | 187.81 | 256.41 | 302.54 | 318.94 | 246.58 | 164.90 | 209.78 | 346.57 |
Average Receivables |
1.61 | 1.84 | 1.68 | 1.08 | 0.83 | 0.85 | 0.79 | 0.67 | 0.41 | 0.17 |
Average Payables |
1.93 | 2.01 | 2.31 | 1.83 | 1.26 | 1.29 | 1.31 | 1.00 | 1.42 | 2.41 |
Average Inventory |
1.81 | 1.86 | 2.33 | 2.75 | 2.90 | 2.38 | 1.73 | 1.62 | 1.13 | 1.13 |
Average Assets |
7.99 | 9.82 | 17.22 | 27.55 | 25.21 | 12.81 | 7.19 | 13.62 | 12.96 | 15.96 |
Average Common Equity |
4.58 | 4.76 | 7.67 | 19.15 | 21.13 | 9.15 | 3.96 | 11.09 | 9.00 | 6.96 |
Columns are period end dates